Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2015 | -19.66 Million USD | -51.19% |
| 2014 | -13 Million USD | -63.7% |
| 2013 | -7.94 Million USD | -3.77% |
| 2012 | -7.2 Million USD | -44.07% |
| 2011 | -5.31 Million USD | -20.39% |
| 2010 | -4.19 Million USD | 50.94% |
| 2009 | -8.94 Million USD | -15.27% |
| 2008 | -8.7 Million USD | -58.49% |
| 2007 | -4.92 Million USD | -224.82% |
| 2006 | -1.31 Million USD | -169.88% |
| 2005 | 2.17 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2015 FY | - USD | -51.19% |
| 2015 Q1 | -3.64 Million USD | -18.68% |
| 2014 Q2 | -2.88 Million USD | 16.98% |
| 2014 Q3 | -3.14 Million USD | -9.09% |
| 2014 Q4 | -3.06 Million USD | 2.6% |
| 2014 Q1 | -3.47 Million USD | -10.35% |
| 2014 FY | - USD | -63.7% |
| 2013 Q1 | -646.71 Thousand USD | -37.7% |
| 2013 Q4 | -3.15 Million USD | -15.14% |
| 2013 Q2 | -1.27 Million USD | -96.81% |
| 2013 Q3 | -2.73 Million USD | -115.07% |
| 2013 FY | - USD | -3.77% |
| 2012 FY | - USD | -44.07% |
| 2012 Q4 | -469.66 Thousand USD | 63.22% |
| 2012 Q3 | -1.27 Million USD | 50.62% |
| 2012 Q2 | -2.58 Million USD | 13.58% |
| 2012 Q1 | -2.99 Million USD | 21.86% |
| 2011 Q2 | -11.56 Thousand USD | 92.54% |
| 2011 Q4 | -3.82 Million USD | -190.28% |
| 2011 FY | - USD | -20.39% |
| 2011 Q1 | -155.1 Thousand USD | 85.93% |
| 2011 Q3 | -1.31 Million USD | -11304.25% |
| 2010 Q4 | -1.1 Million USD | -13.8% |
| 2010 Q2 | -338.67 Thousand USD | 83.11% |
| 2010 Q1 | -2 Million USD | -19.73% |
| 2010 FY | - USD | 50.94% |
| 2010 Q3 | -968.61 Thousand USD | -186.0% |
| 2009 FY | - USD | -15.27% |
| 2009 Q1 | -3.2 Million USD | -65.82% |
| 2009 Q4 | -1.67 Million USD | 11.1% |
| 2009 Q2 | -2.24 Million USD | 29.99% |
| 2009 Q3 | -1.88 Million USD | 15.92% |
| 2008 Q3 | -912.09 Thousand USD | 55.35% |
| 2008 Q1 | -1.75 Million USD | -93.72% |
| 2008 FY | - USD | -58.49% |
| 2008 Q4 | -1.92 Million USD | -111.6% |
| 2008 Q2 | -2.04 Million USD | -16.6% |
| 2007 FY | - USD | -224.82% |
| 2007 Q4 | -904.39 Thousand USD | 0.18% |
| 2007 Q3 | -906.06 Thousand USD | 62.69% |
| 2007 Q2 | -2.42 Million USD | -253.62% |
| 2007 Q1 | -686.75 Thousand USD | -3.45% |
| 2006 Q4 | -663.86 Thousand USD | -21.03% |
| 2006 FY | - USD | -169.88% |
| 2006 Q3 | -548.51 Thousand USD | -142.85% |
| 2006 Q1 | 1.26 Million USD | 0.0% |
| 2006 Q2 | 1.27 Million USD | 0.87% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -1590.972% |
| Arrayit Corporation | -3.07 Million USD | -539.026% |
| Atlantic International Corp. | -5.38 Million USD | -264.891% |
| Biocept, Inc. | -30.24 Million USD | 34.969% |
| Bioqual, Inc. | 3.03 Million USD | 748.563% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -2496.6% |
| DermTech, Inc. | -97.89 Million USD | 79.911% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.675% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 2.848% |
| iMD Companies, Inc. | -154.65 Thousand USD | -12615.717% |
| IDenta Corp. | 71.58 Thousand USD | 27571.468% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 612.536% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 50929.672% |
| InVitro International | 6680.00 USD | 294501.198% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -261.773% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -161973.512% |
| Medical Imaging Corp. | -896.74 Thousand USD | -2093.05% |
| NovelStem International Corp. | -3.78 Million USD | -419.468% |
| Optigenex Inc. | -1.18 Million USD | -1557.167% |
| PharmChem, Inc. | 1.05 Million USD | 1966.181% |
| Proteome Sciences plc | -1.13 Million USD | -1629.639% |
| Rennova Health, Inc. | -234.81 Thousand USD | -8275.104% |
| RushNet, Inc. | -614.85 Thousand USD | -3098.493% |
| ScreenPro Security Inc. | -3.43 Million USD | -472.537% |
| Stella Diagnostics Inc. | -5.7 Million USD | -244.568% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -91.487% |
| Todos Medical Ltd. | -9.39 Million USD | -109.346% |